{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    7,
    8,
    9,
    13,
    14,
    15,
    18,
    19,
    20,
    22,
    23,
    24,
    25,
    26,
    27
  ],
  "modelUsed": "gemini-3-flash-preview",
  "studyDesignStructure": {
    "studyArms": [
      {
        "id": "arm_1",
        "name": "Induction: Placebo IV",
        "type": {
          "code": "Placebo Comparator Arm",
          "codeSystem": "USDM",
          "decode": "Placebo Comparator Arm"
        },
        "instanceType": "StudyArm",
        "description": "Subjects receive placebo IV at Week 0"
      },
      {
        "id": "arm_2",
        "name": "Induction: Ustekinumab 130 mg IV",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Subjects receive a fixed dose of 130 mg IV at Week 0"
      },
      {
        "id": "arm_3",
        "name": "Induction: Ustekinumab ~6 mg/kg IV",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Weight-range-based dosing: 260 mg (<=55 kg), 390 mg (>55 to <=85 kg), or 520 mg (>85 kg) IV at Week 0"
      },
      {
        "id": "arm_4",
        "name": "Maintenance: Placebo SC",
        "type": {
          "code": "Placebo Comparator Arm",
          "codeSystem": "USDM",
          "decode": "Placebo Comparator Arm"
        },
        "instanceType": "StudyArm",
        "description": "Subjects receive placebo SC at maintenance Week 0 and scheduled visits"
      },
      {
        "id": "arm_5",
        "name": "Maintenance: Ustekinumab 90 mg SC q12w",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Subjects receive 90 mg SC every 12 weeks"
      },
      {
        "id": "arm_6",
        "name": "Maintenance: Ustekinumab 90 mg SC q8w",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Subjects receive 90 mg SC every 8 weeks"
      }
    ],
    "studyCells": [
      {
        "id": "cell_1",
        "armId": "arm_1",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_1"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_2",
        "armId": "arm_1",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_2"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_3",
        "armId": "arm_1",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_3"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_4",
        "armId": "arm_1",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_4"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_5",
        "armId": "arm_2",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_5"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_6",
        "armId": "arm_2",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_6"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_7",
        "armId": "arm_2",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_7"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_8",
        "armId": "arm_2",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_8"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_9",
        "armId": "arm_3",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_9"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_10",
        "armId": "arm_3",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_10"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_11",
        "armId": "arm_3",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_11"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_12",
        "armId": "arm_3",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_12"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_13",
        "armId": "arm_4",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_13"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_14",
        "armId": "arm_4",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_14"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_15",
        "armId": "arm_4",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_15"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_16",
        "armId": "arm_4",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_16"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_17",
        "armId": "arm_5",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_17"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_18",
        "armId": "arm_5",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_18"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_19",
        "armId": "arm_5",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_19"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_20",
        "armId": "arm_5",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_20"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_21",
        "armId": "arm_6",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_21"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_22",
        "armId": "arm_6",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_22"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_23",
        "armId": "arm_6",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_23"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_24",
        "armId": "arm_6",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_24"
        ],
        "instanceType": "StudyCell"
      }
    ],
    "studyCohorts": [
      {
        "id": "cohort_1",
        "name": "Biologic Failure",
        "instanceType": "StudyCohort",
        "characteristic": "Subjects who have failed or are intolerant to biologic therapy (e.g., TNF antagonists)"
      },
      {
        "id": "cohort_2",
        "name": "Conventional Therapy Failure",
        "instanceType": "StudyCohort",
        "characteristic": "Subjects who have failed or are intolerant to conventional therapy but not biologics"
      },
      {
        "id": "cohort_3",
        "name": "Primary Maintenance Population",
        "instanceType": "StudyCohort",
        "characteristic": "Subjects in clinical response to IV ustekinumab induction"
      }
    ],
    "studyElements": [
      {
        "id": "elem_1",
        "name": "Induction: Placebo IV - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Placebo IV during Screening"
      },
      {
        "id": "elem_2",
        "name": "Induction: Placebo IV - Induction Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Placebo IV during Induction Study"
      },
      {
        "id": "elem_3",
        "name": "Induction: Placebo IV - Maintenance Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Placebo IV during Maintenance Study"
      },
      {
        "id": "elem_4",
        "name": "Induction: Placebo IV - Long-Term Extension",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Placebo IV during Long-Term Extension"
      },
      {
        "id": "elem_5",
        "name": "Induction: Ustekinumab 130 mg IV - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Ustekinumab 130 mg IV during Screening"
      },
      {
        "id": "elem_6",
        "name": "Induction: Ustekinumab 130 mg IV - Induction Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Ustekinumab 130 mg IV during Induction Study"
      },
      {
        "id": "elem_7",
        "name": "Induction: Ustekinumab 130 mg IV - Maintenance Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Ustekinumab 130 mg IV during Maintenance Study"
      },
      {
        "id": "elem_8",
        "name": "Induction: Ustekinumab 130 mg IV - Long-Term Extension",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Ustekinumab 130 mg IV during Long-Term Extension"
      },
      {
        "id": "elem_9",
        "name": "Induction: Ustekinumab ~6 mg/kg IV - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Ustekinumab ~6 mg/kg IV during Screening"
      },
      {
        "id": "elem_10",
        "name": "Induction: Ustekinumab ~6 mg/kg IV - Induction Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Ustekinumab ~6 mg/kg IV during Induction Study"
      },
      {
        "id": "elem_11",
        "name": "Induction: Ustekinumab ~6 mg/kg IV - Maintenance Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Ustekinumab ~6 mg/kg IV during Maintenance Study"
      },
      {
        "id": "elem_12",
        "name": "Induction: Ustekinumab ~6 mg/kg IV - Long-Term Extension",
        "instanceType": "StudyElement",
        "description": "Treatment period for Induction: Ustekinumab ~6 mg/kg IV during Long-Term Extension"
      },
      {
        "id": "elem_13",
        "name": "Maintenance: Placebo SC - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Placebo SC during Screening"
      },
      {
        "id": "elem_14",
        "name": "Maintenance: Placebo SC - Induction Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Placebo SC during Induction Study"
      },
      {
        "id": "elem_15",
        "name": "Maintenance: Placebo SC - Maintenance Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Placebo SC during Maintenance Study"
      },
      {
        "id": "elem_16",
        "name": "Maintenance: Placebo SC - Long-Term Extension",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Placebo SC during Long-Term Extension"
      },
      {
        "id": "elem_17",
        "name": "Maintenance: Ustekinumab 90 mg SC q12w - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Ustekinumab 90 mg SC q12w during Screening"
      },
      {
        "id": "elem_18",
        "name": "Maintenance: Ustekinumab 90 mg SC q12w - Induction Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Ustekinumab 90 mg SC q12w during Induction Study"
      },
      {
        "id": "elem_19",
        "name": "Maintenance: Ustekinumab 90 mg SC q12w - Maintenance Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Ustekinumab 90 mg SC q12w during Maintenance Study"
      },
      {
        "id": "elem_20",
        "name": "Maintenance: Ustekinumab 90 mg SC q12w - Long-Term Extension",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Ustekinumab 90 mg SC q12w during Long-Term Extension"
      },
      {
        "id": "elem_21",
        "name": "Maintenance: Ustekinumab 90 mg SC q8w - Screening",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Ustekinumab 90 mg SC q8w during Screening"
      },
      {
        "id": "elem_22",
        "name": "Maintenance: Ustekinumab 90 mg SC q8w - Induction Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Ustekinumab 90 mg SC q8w during Induction Study"
      },
      {
        "id": "elem_23",
        "name": "Maintenance: Ustekinumab 90 mg SC q8w - Maintenance Study",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Ustekinumab 90 mg SC q8w during Maintenance Study"
      },
      {
        "id": "elem_24",
        "name": "Maintenance: Ustekinumab 90 mg SC q8w - Long-Term Extension",
        "instanceType": "StudyElement",
        "description": "Treatment period for Maintenance: Ustekinumab 90 mg SC q8w during Long-Term Extension"
      }
    ],
    "summary": {
      "armCount": 6,
      "cellCount": 24,
      "cohortCount": 3,
      "elementCount": 24
    },
    "studyDesign": {
      "id": "sd_1",
      "name": "Study Design",
      "instanceType": "InterventionalStudyDesign",
      "trialIntentTypes": [
        {
          "code": "Treatment",
          "codeSystem": "USDM",
          "decode": "Treatment"
        }
      ],
      "trialType": {
        "code": "Interventional",
        "codeSystem": "USDM",
        "decode": "Interventional"
      },
      "blindingSchema": {
        "code": "Double Blind",
        "codeSystem": "USDM",
        "decode": "Double Blind"
      },
      "maskedRoles": [
        "Subject",
        "Investigator"
      ],
      "randomizationType": {
        "code": "Randomized",
        "codeSystem": "USDM",
        "decode": "Randomized"
      },
      "allocationRatio": {
        "ratio": "1:1:1"
      },
      "stratificationFactors": [
        "Biologic failure status",
        "Region",
        "Clinical remission status at maintenance baseline"
      ],
      "controlType": {
        "code": "Placebo Control",
        "codeSystem": "USDM",
        "decode": "Placebo Control"
      },
      "armIds": [
        "arm_1",
        "arm_2",
        "arm_3",
        "arm_4",
        "arm_5",
        "arm_6"
      ],
      "cohortIds": [
        "cohort_1",
        "cohort_2",
        "cohort_3"
      ],
      "therapeuticAreas": [
        "Gastroenterology"
      ]
    }
  },
  "rawResponse": {
    "studyDesign": {
      "type": "Interventional",
      "trialIntentTypes": [
        "Treatment"
      ],
      "blinding": {
        "schema": "Double Blind",
        "maskedRoles": [
          "Subject",
          "Investigator"
        ]
      },
      "randomization": {
        "type": "Randomized",
        "allocationRatio": "1:1:1",
        "stratificationFactors": [
          "Biologic failure status",
          "Region",
          "Clinical remission status at maintenance baseline"
        ]
      },
      "controlType": "Placebo",
      "therapeuticAreas": [
        "Gastroenterology"
      ]
    },
    "arms": [
      {
        "name": "Induction: Placebo IV",
        "type": "Placebo Comparator",
        "description": "Subjects receive placebo IV at Week 0",
        "isTitration": false
      },
      {
        "name": "Induction: Ustekinumab 130 mg IV",
        "type": "Experimental Arm",
        "description": "Subjects receive a fixed dose of 130 mg IV at Week 0",
        "isTitration": false
      },
      {
        "name": "Induction: Ustekinumab ~6 mg/kg IV",
        "type": "Experimental Arm",
        "description": "Weight-range-based dosing: 260 mg (<=55 kg), 390 mg (>55 to <=85 kg), or 520 mg (>85 kg) IV at Week 0",
        "isTitration": false
      },
      {
        "name": "Maintenance: Placebo SC",
        "type": "Placebo Comparator",
        "description": "Subjects receive placebo SC at maintenance Week 0 and scheduled visits",
        "isTitration": false
      },
      {
        "name": "Maintenance: Ustekinumab 90 mg SC q12w",
        "type": "Experimental Arm",
        "description": "Subjects receive 90 mg SC every 12 weeks",
        "isTitration": false
      },
      {
        "name": "Maintenance: Ustekinumab 90 mg SC q8w",
        "type": "Experimental Arm",
        "description": "Subjects receive 90 mg SC every 8 weeks",
        "isTitration": false
      }
    ],
    "cohorts": [
      {
        "name": "Biologic Failure",
        "characteristic": "Subjects who have failed or are intolerant to biologic therapy (e.g., TNF antagonists)"
      },
      {
        "name": "Conventional Therapy Failure",
        "characteristic": "Subjects who have failed or are intolerant to conventional therapy but not biologics"
      },
      {
        "name": "Primary Maintenance Population",
        "characteristic": "Subjects in clinical response to IV ustekinumab induction"
      }
    ],
    "epochs": [
      {
        "name": "Screening",
        "description": "Up to 8 weeks to determine eligibility"
      },
      {
        "name": "Induction Study",
        "description": "Week 0 to Week 8 (or Week 16 for delayed responders)"
      },
      {
        "name": "Maintenance Study",
        "description": "44-week period following successful induction"
      },
      {
        "name": "Long-Term Extension",
        "description": "3-year follow-up after completion of maintenance"
      }
    ]
  }
}